Energy 90.5 Top Music Radio
In December, the FDA approved the first two cell-based gene therapies for treating sickle cell disease: Casgevy and Lyfgenia. And, like any emerging medical technology, the initial use of the innovative gene editing tool has been met with an amalgam of anticipation and anxiety, writes Elizabeth Yuko. Read More Breaking News, Latest News and Videos | CNN
Copyright © 2025. All Rights Reserved.Chole Broadcasting